Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

ABVC BIOPHARMA, INC. (ABVC)

$1.15 -4.17% NASDAQ: ABVC · 15-min delayed
  • FREMONT, California
  • Public · NASDAQ: ABVC
  • 19 employees
$34.6MMarket cap
$509.6KRevenue · FY2024
-$7.9MNet income
19Employees
ABVCNASDAQ
2004IPO

About ABVC BIOPHARMA, INC.

ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2024
$509.6K
Net income
-$7.9M
Total assets
$21.1M
Market cap
$34.6M

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$0
Operating expenses
$7.2M
Operating income
-$7.2M
Income tax
$24.2K
Net income
-$8.4M
EPS (basic)
$-0.39
EPS (diluted)
$-0.39

Balance sheet

Total assets
$21.1M
Current assets
$2.5M
Total liabilities
$7.8M
Current liabilities
$6.2M
Shareholders’ equity
$13.3M

Cash flow

Operating cash flow
-$3.0M
Investing cash flow
-$1.2M
Financing cash flow
$4.6M
Net cash flow
$463.2K

Statements via Polygon.io (SEC filings)

NASDAQ: ABVC
$1.15 -4.17%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.91 $4.74

52-week range

Market cap
$34.6M
EPS (diluted)
$-0.39
Shares outstanding
30.1M
Open
Day range
Prev close
Volume
IPO date
Nov 9, 2004

Abvc Biopharma, Inc. (ABVC) Stock Price

  • Reported a net loss of $7.9M in FY2024.
  • Trading 76% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review ABVC BIOPHARMA, INC..

Write a review
Newsroom

News about ABVC BIOPHARMA, INC.

News & sentiment via Polygon.io

FAQ

Abvc Biopharma, Inc.: frequently asked questions

Is Abvc Biopharma, Inc. an American company?

Abvc Biopharma, Inc. is a US-based company headquartered in Fremont, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Abvc Biopharma, Inc. headquartered?

Abvc Biopharma, Inc. is headquartered in Fremont, California, United States.

Is Abvc Biopharma, Inc. publicly traded?

Yes — Abvc Biopharma, Inc. is a publicly traded company. Its stock trades under the ticker symbol ABVC on the NASDAQ.

What does Abvc Biopharma, Inc. do?

Abvc Biopharma, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →